Purchase of MALDI Biotyper
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement to purchase a MALDI Biotyper system to replace the current Bruker biotyper system in the Salisbury lab, which is no longer serviceable. This MALDI-TOF MS technology procurement is intended for rapid bacterial identification, with specific application to identifying Clostridium botulinum and its neurotoxin. The estimated solicitation release date is April 1, 2026, with an anticipated award date of June 1, 2026.
The estimated award value for this contract ranges from $25,000 to $250,000, and no set-aside restrictions apply to this procurement opportunity. The contract falls under NAICS code 541990 (All Other Professional, Scientific, and Technical Services). Interested vendors should direct inquiries to the Food and Drug Administration's Acquisition Liaison at hfpacquisitions@fda.hhs.gov.
Forecast text
This is to replace the current Bruker biotyper system in the SA lab, which is no longer serviceable. MALDI-TOF MS technology is used for rapid bacterial identification, and its application to Clostridium botulinum involves identifying the bacterium and its neurotoxin.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast